HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiko Mori Selected Research

IE protocol

11/2021Neoadjuvant chemotherapy for Ewing's sarcoma family tumors of the uterine cervix: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiko Mori Research Topics

Disease

12Neoplasms (Cancer)
01/2024 - 11/2007
7Infections
01/2022 - 01/2011
6Endometriosis
01/2020 - 08/2013
6Myoma
05/2012 - 11/2007
5Disease Progression
01/2023 - 02/2007
4Hemorrhage
01/2023 - 03/2009
4HIV Infections (HIV Infection)
01/2018 - 02/2007
3COVID-19
04/2024 - 12/2022
3Ovarian Neoplasms (Ovarian Cancer)
01/2024 - 01/2022
3Viremia
01/2019 - 01/2016
3Cysts
10/2016 - 11/2010
3Ectopic Pregnancy
09/2012 - 05/2008
3Cicatrix (Scar)
01/2012 - 10/2009
2Rheumatoid Arthritis
04/2023 - 01/2019
2Necrosis
04/2023 - 01/2023
2Endometrial Neoplasms (Endometrial Cancer)
01/2023 - 04/2022
2Carcinosarcoma
01/2023 - 06/2021
2Shock
01/2021 - 01/2021
2Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2018 - 01/2018
2Dermoid Cyst (Dermoid)
09/2012 - 11/2010
2Leiomyoma (Uterine Fibroids)
08/2011 - 11/2007
2Chromosome Aberrations (Chromosome Abnormalities)
01/2011 - 01/2007
2Uterine Hemorrhage (Uterine Bleeding)
03/2010 - 03/2008
2False Aneurysm (Pseudoaneurysm)
10/2009 - 03/2008
1Nausea
01/2024
1Vomiting
01/2024
1Arthralgia (Joint Pain)
11/2023
1Asthma (Bronchial Asthma)
11/2023
1Breast Neoplasms (Breast Cancer)
11/2023
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2023
1Bacterial Infections (Bacterial Infection)
01/2022
1Ewing Sarcoma (Sarcoma, Ewing)
11/2021
1Sepsis (Septicemia)
01/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Septic Shock (Toxic Shock Syndrome)
01/2021
1Soft Tissue Infections
01/2020
1Fibrosis (Cirrhosis)
01/2020

Drug/Important Bio-Agent (IBA)

4EpitopesIBA
01/2018 - 01/2011
3VaccinesIBA
04/2024 - 01/2016
3Messenger RNA (mRNA)IBA
04/2024 - 12/2022
3lipoarabinomannan (LAM)IBA
01/2012 - 05/2008
2Methotrexate (Mexate)FDA LinkGeneric
04/2023 - 02/2011
2Topoisomerase I InhibitorsIBA
01/2023 - 01/2007
2Etoposide (VP 16)FDA LinkGeneric
11/2021 - 01/2007
2Hydroxyindoleacetic AcidIBA
01/2021 - 01/2021
2Serotonin (5 Hydroxytryptamine)IBA
01/2021 - 01/2021
2HLA-B Antigens (HLA-B)IBA
01/2018 - 01/2016
2Hormones (Hormone)IBA
01/2016 - 08/2013
2IronIBA
01/2016 - 12/2015
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
08/2014 - 01/2011
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2024
1Antineoplastic Agents (Antineoplastics)IBA
01/2024
1AntiemeticsIBA
01/2024
1olaparibIBA
01/2024
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
01/2024
1Adenosine Diphosphate (ADP)IBA
01/2024
1niraparibIBA
01/2024
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2024
1Adalimumab (Humira)FDA Link
04/2023
1Antirheumatic Agents (DMARD)IBA
04/2023
1ErbB Receptors (EGF Receptor)IBA
01/2023
1human ERBB2 proteinIBA
01/2023
1Immunoconjugates (Immunoconjugate)IBA
01/2023
1trastuzumab deruxtecanIBA
01/2023
1PlatinumIBA
01/2022
1relebactamIBA
01/2022
1Imipenem Drug Combination Cilastatin (Primaxin)FDA Link
01/2022
1AntigensIBA
01/2022
1Carbapenems (Carbapenem Antibiotics)IBA
01/2022
1Bevacizumab (Avastin)FDA Link
01/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2021
1IfosfamideFDA LinkGeneric
11/2021
1Vincristine (Oncovin)FDA LinkGeneric
11/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021
1AcidsIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1tedizolid phosphateIBA
01/2020
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2020
1AZD4547IBA
01/2019

Therapy/Procedure

10Uterine Myomectomy
05/2012 - 11/2007
6Therapeutics
01/2024 - 01/2015
5Cystectomy
01/2016 - 11/2010
3Drug Therapy (Chemotherapy)
04/2022 - 06/2014
3Hysterectomy
11/2021 - 01/2018
3Salpingo-oophorectomy
08/2011 - 02/2009
2Laparotomy
01/2023 - 05/2008
2Adjuvant Radiotherapy
10/2018 - 01/2018
2Laparoscopes (Laparoscope)
02/2013 - 09/2010
2Vaginal Hysterectomy
10/2011 - 05/2008
2Salpingectomy
08/2011 - 02/2011
2Conservative Treatment
10/2010 - 03/2010
2Uterine Artery Embolization
05/2010 - 08/2009
1Overlapping Surgery
11/2023
1Gastrectomy
01/2023
1Ligation
01/2023
1Punctures
01/2023
1Surgical Instruments (Clip)
01/2023
1IE protocol
11/2021
1Adjuvant Chemotherapy
11/2021
1Neoadjuvant Therapy
11/2021